In the field of cellular biology, single-cell analysis is the study of genomics, transcriptomics, proteomics, metabolomics and cell–cell interactions at the single cell level.
The global Mammalian Single Cell Analysis market was valued at US$ 1536 million in 2023 and is anticipated to reach US$ 2505.9 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 248%.
This report aims to provide a comprehensive presentation of the global market for Mammalian Single Cell Analysis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mammalian Single Cell Analysis.
Report Scope
The Mammalian Single Cell Analysis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mammalian Single Cell Analysis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mammalian Single Cell Analysis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Becton Dickinson and Company
Danaher Corporation
Merck Millipore
Qiagen
Thermo Fisher Scientific
General Electric Company
10x Genomics
Promega Corporation
Illumina
Bio-Rad Laboratories
Fluidigm Corporation
Agilent Technologies
Nanostring Technologies
Tecan Group
Sartorius
Luminex Corporation
Segment by Type
Instruments
Consumables and Reagents
Related Software
Segment by Application
Veterinary Research Centres
Veterinary Hospitals and Diagnostic Labs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mammalian Single Cell Analysis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Mammalian Single Cell Analysis Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Consumables and Reagents
1.2.4 Related Software
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Mammalian Single Cell Analysis Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Research Centres
1.3.3 Veterinary Hospitals and Diagnostic Labs
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mammalian Single Cell Analysis Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Mammalian Single Cell Analysis Growth Trends by Region
2.2.1 Global Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mammalian Single Cell Analysis Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Mammalian Single Cell Analysis Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Mammalian Single Cell Analysis Âé¶¹Ô´´ Dynamics
2.3.1 Mammalian Single Cell Analysis Industry Trends
2.3.2 Mammalian Single Cell Analysis Âé¶¹Ô´´ Drivers
2.3.3 Mammalian Single Cell Analysis Âé¶¹Ô´´ Challenges
2.3.4 Mammalian Single Cell Analysis Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mammalian Single Cell Analysis Players by Revenue
3.1.1 Global Top Mammalian Single Cell Analysis Players by Revenue (2019-2024)
3.1.2 Global Mammalian Single Cell Analysis Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Mammalian Single Cell Analysis Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mammalian Single Cell Analysis Revenue
3.4 Global Mammalian Single Cell Analysis Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Mammalian Single Cell Analysis Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mammalian Single Cell Analysis Revenue in 2023
3.5 Mammalian Single Cell Analysis Key Players Head office and Area Served
3.6 Key Players Mammalian Single Cell Analysis Product Solution and Service
3.7 Date of Enter into Mammalian Single Cell Analysis Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Mammalian Single Cell Analysis Breakdown Data by Type
4.1 Global Mammalian Single Cell Analysis Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Mammalian Single Cell Analysis Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Mammalian Single Cell Analysis Breakdown Data by Application
5.1 Global Mammalian Single Cell Analysis Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Mammalian Single Cell Analysis Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Mammalian Single Cell Analysis Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Mammalian Single Cell Analysis Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mammalian Single Cell Analysis Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Mammalian Single Cell Analysis Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mammalian Single Cell Analysis Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Mammalian Single Cell Analysis Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mammalian Single Cell Analysis Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Mammalian Single Cell Analysis Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mammalian Single Cell Analysis Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Mammalian Single Cell Analysis Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Mammalian Single Cell Analysis Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton Dickinson and Company
11.1.1 Becton Dickinson and Company Company Detail
11.1.2 Becton Dickinson and Company Business Overview
11.1.3 Becton Dickinson and Company Mammalian Single Cell Analysis Introduction
11.1.4 Becton Dickinson and Company Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.1.5 Becton Dickinson and Company Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Detail
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Mammalian Single Cell Analysis Introduction
11.2.4 Danaher Corporation Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.2.5 Danaher Corporation Recent Development
11.3 Merck Millipore
11.3.1 Merck Millipore Company Detail
11.3.2 Merck Millipore Business Overview
11.3.3 Merck Millipore Mammalian Single Cell Analysis Introduction
11.3.4 Merck Millipore Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.3.5 Merck Millipore Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Mammalian Single Cell Analysis Introduction
11.4.4 Qiagen Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.4.5 Qiagen Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Mammalian Single Cell Analysis Introduction
11.5.4 Thermo Fisher Scientific Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 General Electric Company
11.6.1 General Electric Company Company Detail
11.6.2 General Electric Company Business Overview
11.6.3 General Electric Company Mammalian Single Cell Analysis Introduction
11.6.4 General Electric Company Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.6.5 General Electric Company Recent Development
11.7 10x Genomics
11.7.1 10x Genomics Company Detail
11.7.2 10x Genomics Business Overview
11.7.3 10x Genomics Mammalian Single Cell Analysis Introduction
11.7.4 10x Genomics Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.7.5 10x Genomics Recent Development
11.8 Promega Corporation
11.8.1 Promega Corporation Company Detail
11.8.2 Promega Corporation Business Overview
11.8.3 Promega Corporation Mammalian Single Cell Analysis Introduction
11.8.4 Promega Corporation Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.8.5 Promega Corporation Recent Development
11.9 Illumina
11.9.1 Illumina Company Detail
11.9.2 Illumina Business Overview
11.9.3 Illumina Mammalian Single Cell Analysis Introduction
11.9.4 Illumina Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.9.5 Illumina Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Mammalian Single Cell Analysis Introduction
11.10.4 Bio-Rad Laboratories Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Fluidigm Corporation
11.11.1 Fluidigm Corporation Company Detail
11.11.2 Fluidigm Corporation Business Overview
11.11.3 Fluidigm Corporation Mammalian Single Cell Analysis Introduction
11.11.4 Fluidigm Corporation Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.11.5 Fluidigm Corporation Recent Development
11.12 Agilent Technologies
11.12.1 Agilent Technologies Company Detail
11.12.2 Agilent Technologies Business Overview
11.12.3 Agilent Technologies Mammalian Single Cell Analysis Introduction
11.12.4 Agilent Technologies Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.12.5 Agilent Technologies Recent Development
11.13 Nanostring Technologies
11.13.1 Nanostring Technologies Company Detail
11.13.2 Nanostring Technologies Business Overview
11.13.3 Nanostring Technologies Mammalian Single Cell Analysis Introduction
11.13.4 Nanostring Technologies Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.13.5 Nanostring Technologies Recent Development
11.14 Tecan Group
11.14.1 Tecan Group Company Detail
11.14.2 Tecan Group Business Overview
11.14.3 Tecan Group Mammalian Single Cell Analysis Introduction
11.14.4 Tecan Group Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.14.5 Tecan Group Recent Development
11.15 Sartorius
11.15.1 Sartorius Company Detail
11.15.2 Sartorius Business Overview
11.15.3 Sartorius Mammalian Single Cell Analysis Introduction
11.15.4 Sartorius Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.15.5 Sartorius Recent Development
11.16 Luminex Corporation
11.16.1 Luminex Corporation Company Detail
11.16.2 Luminex Corporation Business Overview
11.16.3 Luminex Corporation Mammalian Single Cell Analysis Introduction
11.16.4 Luminex Corporation Revenue in Mammalian Single Cell Analysis Business (2019-2024)
11.16.5 Luminex Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Becton Dickinson and Company
Danaher Corporation
Merck Millipore
Qiagen
Thermo Fisher Scientific
General Electric Company
10x Genomics
Promega Corporation
Illumina
Bio-Rad Laboratories
Fluidigm Corporation
Agilent Technologies
Nanostring Technologies
Tecan Group
Sartorius
Luminex Corporation
Ìý
Ìý
*If Applicable.